The role of selective estrogen receptor modulators on breast cancer: From tamoxifen to raloxifene

Taiwanese Journal of Obstetrics and Gynecology

Volumn 47, Issue 1, 2008, Pages 24-31

  Lee, Wen Ling ^a,b   Cheng, Ming Huei ^b,c   Chao, Hsiang Tai ^b,c   Wang, Peng Hui ^b,c  

^a Chen Hsin Rehabilitation Medical Center   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Estrogen; Estrogen receptor; Raloxifene; Selective estrogen receptor modulator; Tamoxifen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

BLADDER DISEASE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER HORMONE THERAPY; CANCER RECURRENCE; CATARACT; CELL PROLIFERATION; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; DRUG EFFICACY; DYSPAREUNIA; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FRAGILITY FRACTURE; GENE EXPRESSION; GOLD STANDARD; HUMAN; LEG CRAMP; LUNG EMBOLISM; MUSCULOSKELETAL DISEASE; OSTEOPOROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTMENOPAUSE; REVIEW; RISK REDUCTION; SIDE EFFECT; STROKE; TREATMENT OUTCOME; VASOMOTOR DISORDER; WEIGHT GAIN;

EID: 42949125058     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(08)60051-0     Document Type: Review

References (56)